Using JAK inhibitors with locally delivered immunosuppression to target islet graft rejection

  • Thomas, Helen E. (Primary Chief Investigator (PCI))
  • Kay, Thomas W.H. (Chief Investigator (CI))
  • O'Connell, Philip J (Chief Investigator (CI))
  • Voelcker, Nicolas (Chief Investigator (CI))
  • Rogers, Natasha (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/22 → 30/06/24

Keywords

  • Type 1 diabetes
  • JAK inhibitors
  • nanoparticles